Cargando…

Superior efficacy of Adalimumab in treating childhood refractory chronic uveitis when used as first biologic

Detalles Bibliográficos
Autores principales: Simonini, G, Taddio, A, Cattalini, M, Caputo, R, DeLibero, C, Pagnini, I, Naviglio, S, Lepore, L, Cimaz, R
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2011
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3194581/
http://dx.doi.org/10.1186/1546-0096-9-S1-P220
_version_ 1782214004382367744
author Simonini, G
Taddio, A
Cattalini, M
Caputo, R
DeLibero, C
Pagnini, I
Naviglio, S
Lepore, L
Cimaz, R
author_facet Simonini, G
Taddio, A
Cattalini, M
Caputo, R
DeLibero, C
Pagnini, I
Naviglio, S
Lepore, L
Cimaz, R
author_sort Simonini, G
collection PubMed
description
format Online
Article
Text
id pubmed-3194581
institution National Center for Biotechnology Information
language English
publishDate 2011
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-31945812011-10-18 Superior efficacy of Adalimumab in treating childhood refractory chronic uveitis when used as first biologic Simonini, G Taddio, A Cattalini, M Caputo, R DeLibero, C Pagnini, I Naviglio, S Lepore, L Cimaz, R Pediatr Rheumatol Online J Poster Presentation BioMed Central 2011-09-14 /pmc/articles/PMC3194581/ http://dx.doi.org/10.1186/1546-0096-9-S1-P220 Text en Copyright ©2011 Simonini et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Poster Presentation
Simonini, G
Taddio, A
Cattalini, M
Caputo, R
DeLibero, C
Pagnini, I
Naviglio, S
Lepore, L
Cimaz, R
Superior efficacy of Adalimumab in treating childhood refractory chronic uveitis when used as first biologic
title Superior efficacy of Adalimumab in treating childhood refractory chronic uveitis when used as first biologic
title_full Superior efficacy of Adalimumab in treating childhood refractory chronic uveitis when used as first biologic
title_fullStr Superior efficacy of Adalimumab in treating childhood refractory chronic uveitis when used as first biologic
title_full_unstemmed Superior efficacy of Adalimumab in treating childhood refractory chronic uveitis when used as first biologic
title_short Superior efficacy of Adalimumab in treating childhood refractory chronic uveitis when used as first biologic
title_sort superior efficacy of adalimumab in treating childhood refractory chronic uveitis when used as first biologic
topic Poster Presentation
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3194581/
http://dx.doi.org/10.1186/1546-0096-9-S1-P220
work_keys_str_mv AT simoninig superiorefficacyofadalimumabintreatingchildhoodrefractorychronicuveitiswhenusedasfirstbiologic
AT taddioa superiorefficacyofadalimumabintreatingchildhoodrefractorychronicuveitiswhenusedasfirstbiologic
AT cattalinim superiorefficacyofadalimumabintreatingchildhoodrefractorychronicuveitiswhenusedasfirstbiologic
AT caputor superiorefficacyofadalimumabintreatingchildhoodrefractorychronicuveitiswhenusedasfirstbiologic
AT deliberoc superiorefficacyofadalimumabintreatingchildhoodrefractorychronicuveitiswhenusedasfirstbiologic
AT pagninii superiorefficacyofadalimumabintreatingchildhoodrefractorychronicuveitiswhenusedasfirstbiologic
AT naviglios superiorefficacyofadalimumabintreatingchildhoodrefractorychronicuveitiswhenusedasfirstbiologic
AT leporel superiorefficacyofadalimumabintreatingchildhoodrefractorychronicuveitiswhenusedasfirstbiologic
AT cimazr superiorefficacyofadalimumabintreatingchildhoodrefractorychronicuveitiswhenusedasfirstbiologic